Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
Alvar AgustiJosé Luis Lopez-CamposMarc MiravitllesJuan Jose Soler-CataluñaJose Maria MarinBorja G CosioBernardino Alcázar-NavarreteJose Maria Echave-SustaetaCiro CasanovaGerman Peces-BarbaJuan Pablo de-TorresAlberto Fernandez-VillarJulio AncocheaFelipe Villar-AlvarezMiguel Roman-RodriguezJesus MolinaJuan Luis Garcia-RiveroCruz GonzalezPatricia SobradilloRosa FanerCarolina PeñaRaj SharmaJosé Luis IzquierdoBartolome R CelliPublished in: Archivos de bronconeumologia (2024)
The ANTES B+ study is the first to: (1) explore the efficacy and safety of triple therapy in a population of B+ COPD patients and (2) use a composite index (CC) as the primary result of a COPD trial.